Degree of change in right ventricular adaptation measures during axillary Impella support informs risk stratification for early, severe right heart failure following durable LVAD implantation.


Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
03 2022
Historique:
received: 19 02 2021
revised: 13 09 2021
accepted: 08 11 2021
pubmed: 10 1 2022
medline: 1 4 2022
entrez: 9 1 2022
Statut: ppublish

Résumé

Risk assessment for early, severe right heart failure (RHF) after LVAD implantation remains imperfect. We sought to define the differences in RV adaptation and load after axillary Impella support between patients who experienced RHF and those who did not. Seventeen of 18 patients included were deemed intermediate or high risk for RHF by EUROMACS-RHF score. Before Impella insertion, RV adaptation parameters (RAP, RAP:PCWP, PAPi) were worse in the non-RHF group compared to the RHF group. In both groups, RV load parameters (effective pulmonary arterial elastance, pulmonary vascular resistance, and pulmonary vascular compliance) improved after Impella insertion. Lesser improvements in RV adaptation were seen in the RHF group. Moreover, load-to-adaptation relationships (E

Identifiants

pubmed: 34998630
pii: S1053-2498(21)02585-7
doi: 10.1016/j.healun.2021.11.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

279-282

Informations de copyright

Copyright © 2021 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Auteurs

Brian Hsi (B)

Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.

Denny Joseph (D)

Department of Internal Medicine, Houston Methodist Hospital, Houston, Texas.

Barry Trachtenberg (B)

Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.

Arvind Bhimaraj (A)

Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.

Erik E Suarez (EE)

Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.

Jiaqiong Xu (J)

Center for Outcomes Research, Houston Methodist Research Institute Houston, Texas.

Ashrith Guha (A)

Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas. Electronic address: gashrith@houstonmethodist.org.

Ju H Kim (JH)

Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas. Electronic address: jhkim3@houstonmethodist.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH